In S. Fyodorov Eye Microsurgery Federal State Institution we use anti-VEGF agents Eylea (Bayer, Germany) and Lucentis (Novartis Pharma, Switzerland) and also intravitreal dexamethasone implant Ozurdex (Allergan, Ireland).
To determine the treatment strategy, all patients undergo retinal examination using the most modern equipment. Intravital injections are given in a sterile operating room, which is crucial for ensuring the safety of treatment.